Sunil Singhal, MD
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Philadelphia, PANPI 1528124898
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $4,721 of the $6,439 with a category attached, or 73.3%. Covidien LP accounts for 95.7% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $6,210 and has fallen 99.2% since, to $47 in 2025. That places this record below the midpoint for thoracic surgery (cardiothoracic vascular surgery) clinicians in PA, where the typical reported total is $5,177.
Across 9 payments — averaging $715.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Covidien LP$6K
- AstraZeneca$124
- Janssen Research & Development, LLC$49
- Astellas Pharma US Inc$47
- Johnson & Johnson$38
- Biotronik Inc.$21
Across 7 payments — averaging $1900.41 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- KARL Storz Endoscopy-america$13K
What the payments were for
- Consulting fees$4,72173%
- Travel & lodging$1,04116%
- Food & beverage$67811%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Covidien LP | 4 | $6,161 |
| AstraZeneca | 1 | $124 |
| Janssen Research & Development, LLC | 1 | $49 |
| Astellas Pharma US Inc | 1 | $47 |
| Johnson & Johnson | 1 | $38 |
| Biotronik Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- superDimension$6,161
How this compares
$6,439 in reported general payments places this provider in the 50th percentile of 314 thoracic surgery (cardiothoracic vascular surgery) providers in Pennsylvania.
See all thoracic surgery (cardiothoracic vascular surgery) providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other thoracic surgery (cardiothoracic vascular surgery) in Philadelphia
- Mark AndersonPhiladelphia$527K
- Michael AckerPhiladelphia$271K
- Wilson SzetoPhiladelphia$252K
- Nimesh DesaiPhiladelphia$203K
- Nathaniel EvansPhiladelphia$187K
- Marisa CevascoPhiladelphia$186K
- Pavan AtluriPhiladelphia$165K
- Chase BrownPhiladelphia$137K
- Olugbenga OkusanyaPhiladelphia$132K
- Michael IbrahimPhiladelphia$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.